AstraZeneca sees higher 2022 sales, but COVID-19 boost waning
AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade on Thursday (Feb 10) after beating fourth-quarter profit expectations, but warned the boost from its COVID-19 products would fall.
The…